Endometrial Cancer Clinical Trials

110 studies are recruiting for endometrial cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 5

1. A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

   The purpose of this study is to investigate the efficacy and safety of the lifileucel regimen in participants with previously treated endometrial cancer.

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   Honor Health, Phoenix, Arizona

   Locations

   12 in total

   Run by

   Iovance Biotherapeutics, Inc.

   See if you can join NCT06481592 on ClinicalTrials.gov

2. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

   International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

   Stage

   Not phased

   Ages

   Any age

   Site

   Massive Bio SYNERGY-AI site, Birmingham, Alabama

   Locations

   68 in total

   Run by

   Massive Bio, Inc.

   See if you can join NCT03452774 on ClinicalTrials.gov

3. Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

   This is a prospective, multi-center, randomized non-inferiority phase III study to evaluate if patients undergoing a minimally invasive surgery for early stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus pat…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Baylor College of Medicine- McNair Campus, Houston, Texas

   Locations

   5 in total

   Run by

   Anthony Costales, MD

   See if you can join NCT04586959 on ClinicalTrials.gov

4. Mindfulness in Endometrial and Cervical Cancer

   Patients with endometrial cancer who will be undergoing surgery or patients with cervical cancer who will be treated with chemoradiation will be randomized to utilize the Headspace smartphone application or not prior to their anticipated treatment.

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Saint Louis University, St Louis, Missouri

   Run by

   St. Louis University

   See if you can join NCT04512144 on ClinicalTrials.gov

5. A Beta-only IL-2 ImmunoTherapY Study

   This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor activity of MDNA11 alone or in combination with a checkpoint inhibitor in patients with advanced solid tumors.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Sharp Memorial Hospital, San Diego, California

   Locations

   27 in total

   Run by

   Medicenna Therapeutics, Inc.

   See if you can join NCT05086692 on ClinicalTrials.gov

6. Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers

   This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Wellspan Health, York, Pennsylvania

   Run by

   WellSpan Health

   See if you can join NCT04570553 on ClinicalTrials.gov

7. BP1001-A in Patients With Advanced or Recurrent Solid Tumors

   This is a phase I, open-label, study of BP1001-A in participants with advanced or recurrent solid tumors. The dose escalation phase will determine the safety and the maximum tolerated dose (MTD) or maximum administered dose (MAD) of BP1001-A as a single agent. After the MTD or MAD of BP1001-A is es…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Holy Cross Hospital, Silver Spring, Maryland

   Locations

   4 in total

   Run by

   Bio-Path Holdings, Inc.

   See if you can join NCT04196257 on ClinicalTrials.gov

8. Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

   RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois

   Run by

   Northwestern University

   See if you can join NCT00005095 on ClinicalTrials.gov

9. Comprehensive Outcomes for After Cancer Health

   This study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have completed primary therapy for cancer. Up to 625 individuals with diverse cancer diagnoses will be enrolled across up to 8 clinical sites to pa…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Dana Farber Cancer Institute, Boston, Massachusetts

   Locations

   7 in total

   Run by

   Pack Health

   See if you can join NCT05349227 on ClinicalTrials.gov

10. Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

    This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have achieved complete response or partial response on chemotherapy. The study will be conducted in 2 parts. Part 1 will evaluate safety and efficacy of two different doses …

    Stage

    Phase 2

    Ages

    18 and older

    Site

    Kaiser Permanente Center, Vallejo, California

    Locations

    83 in total

    Run by

    Kartos Therapeutics, Inc.

    See if you can join NCT05797831 on ClinicalTrials.gov